How coronavirus could affect emerging-market debt | Manulife Investment Management

Risk assets moved lower after the Centers for Disease Control and Prevention (CDC) press conference on February 25, where officials noted it’s not a matter of if, but a question of when the virus will spread in the United States, adding that a global pandemic was likely. The director of the CDC later assured, however, that steps taken by the United States to contain the virus have worked and that the country is well prepared to deal with an outbreak.¹

The fallout has sent U.S. Treasury yields to record lows and the market is pricing in about 75 basis points of rate cuts from the U.S. Federal Reserve (Fed) over the next year.² The potential for a broader disruption in economic activity—and global growth—looks increasingly likely and supply chain ramifications could be sizable and global in nature.

Global growth expectations have already been revised lower and the overall expectation is for a gradual recovery to take place during the second and third quarter of the year instead of initial estimates for a sharp “V-shaped” recovery.

In the past weeks, concerns about the impact of the outbreak have evolved from a “demand shock” to a broader “supply shock” as a result of the interruption to the supply chain—mainly in the auto sector (e.g., South Korea, Japan)—and to some extent pharmaceuticals, electronics, and broad manufacturing sector.

Expectations of continued monetary policy support by G3 central banks³ are now complemented by calls for expansionary fiscal policy measures. But there appears to be limited scope for immediate action among G3 economies—the United States is gearing up for its presidential election in November, the European Union continues to be mired by a lack of political agreement over many issues, while Japan looks overextended (from a debt perspective).

In our view, caution is warranted in emerging markets, primarily in segments of the asset class with lower levels of participation by crossover buyers. Examples include areas such as non-investment sovereign credits, distressed situations (e.g., Argentina, Ecuador, and Lebanon), and select Asia high-yield credits (given their high refinancing needs that can make them reliant on a market that has become less accommodative to new issues than before).

That said, technicals remain supportive for the broader asset class, with aggregate refinancing needs for both sovereign and corporate credits remaining limited in 2020. The first quarter of the year saw a significant amount of maturities and coupon payments, while supply has been limited since the end of January.

While it’s still impossible to assess the true economic cost of the outbreak, the ongoing repricing of risk in the markets could ultimately lead to opportunities, especially for those with a longer investment horizon. Until then, caution and selectivity will remain the order of the day.

1 “CDC official warns Americans it's not a question of if coronavirus will spread, but when,” CNN.com, February 26, 2020. 2 Bloomberg, as of February 27, 2020. 3 G3 central banks refer to the U.S. Federal Reserve, the Bank of Japan, and the European Central Bank. G3 economies refer to the United States, Japan, and the eurozone.

Important disclosures

Investing involves risks, including the potential loss of principal. Financial markets are volatile and can fluctuate significantly in response to company, industry, political, regulatory, market, or economic developments. These risks are magnified for investments made in emerging markets. Currency risk is the risk that fluctuations in exchange rates may adversely affect the value of a portfolio’s investments.

The information provided does not take into account the suitability, investment objectives, financial situation, or particular needs of any specific person. You should consider the suitability of any type of investment for your circumstances and, if necessary, seek professional advice.

This material, intended for the exclusive use by the recipients who are allowable to receive this document under the applicable laws and regulations of the relevant jurisdictions, was produced by, and the opinions expressed are those of, Manulife Investment Management as of the date of this publication, and are subject to change based on market and other conditions. The information and/or analysis contained in this material have been compiled or arrived at from sources believed to be reliable, but Manulife Investment Management does not make any representation as to their accuracy, correctness, usefulness, or completeness and does not accept liability for any loss arising from the use of the information and/or analysis contained. The information in this material may contain projections or other forward-looking statements regarding future events, targets, management discipline, or other expectations, and is only as current as of the date indicated. The information in this document, including statements concerning financial market trends, are based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Manulife Investment Management disclaims any responsibility to update such information.

Neither Manulife Investment Management or its affiliates, nor any of their directors, officers or employees shall assume any liability or responsibility for any direct or indirect loss or damage or any other consequence of any person acting or not acting in reliance on the information contained herein. All overviews and commentary are intended to be general in nature and for current interest. While helpful, these overviews are no substitute for professional tax, investment or legal advice. Clients should seek professional advice for their particular situation. Neither Manulife, Manulife Investment Management, nor any of their affiliates or representatives is providing tax, investment or legal advice. Past performance does not guarantee future results. This material was prepared solely for informational purposes, does not constitute a recommendation, professional advice, an offer or an invitation by or on behalf of Manulife Investment Management to any person to buy or sell any security or adopt any investment strategy, and is no indication of trading intent in any fund or account managed by Manulife Investment Management. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment. Diversification or asset allocation does not guarantee a profit nor protect against loss in any market. Unless otherwise specified, all data is sourced from Manulife Investment Management.

Manulife Investment Management

Manulife Investment Management is the global wealth and asset management segment of Manulife Financial Corporation. We draw on more than 150 years of financial stewardship to partner with clients across our institutional, retail, and retirement businesses globally. Our specialist approach to money management includes the highly differentiated strategies of our fixed-income, specialized equity, multi-asset solutions, and private markets teams—along with access to specialized, unaffiliated asset managers from around the world through our multimanager model.

These materials have not been reviewed by, are not registered with any securities or other regulatory authority, and may, where appropriate, be distributed by the following Manulife entities in their respective jurisdictions. Additional information about Manulife Investment Management may be found at www.manulifeam.com.

Australia: Hancock Natural Resource Group Australasia Pty Limited, Manulife Investment Management (Hong Kong) Limited. Brazil: Hancock Asset Management Brasil Ltda. Canada: Manulife Investment Management Limited, Manulife Investment Management Distributors Inc., Manulife Investment Management (North America) Limited, Manulife Investment Management Private Markets (Canada) Corp. China: Manulife Overseas Investment Fund Management (Shanghai) Limited Company. European Economic Area and United Kingdom: Manulife Investment Management (Europe) Ltd. which is authorised and regulated by the Financial Conduct Authority, Manulife Investment Management (Ireland) Ltd. which is authorised and regulated by the Central Bank of Ireland Hong Kong: Manulife Investment Management (Hong Kong) Limited. Indonesia: PT Manulife Aset Manajemen Indonesia. Japan: Manulife Asset Management (Japan) Limited. Malaysia: Manulife Investment Management (M) Berhad (formerly known as Manulife Asset Management Services Berhad) 200801033087 (834424-U) Philippines: Manulife Asset Management and Trust Corporation. Singapore: Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G) Switzerland: Manulife IM (Switzerland) LLC. Taiwan: Manulife Investment Management (Taiwan) Co. Ltd. Thailand: Manulife Asset Management (Thailand) Company Limited. United States: John Hancock Investment Management LLC, Manulife Investment Management (US) LLC, Manulife Investment Management Private Markets (US) LLC and Hancock Natural Resource Group, Inc. Vietnam: Manulife Investment Fund Management (Vietnam) Company Limited.

Manulife Investment Management, the Stylized M Design, and Manulife Investment Management & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates under license.

510629